Australia Polymyositis Market Size & Outlook, 2026-2034


Australia Polymyositis Market Insights

  • According to Reed Intelligence analysis, the Australia Polymyositis Market size was USD 13.79 Million in 2025 and is projected to reach USD 24.74 Million by 2034.
  • The Australia market is projected to grow at a CAGR of 6.66% between 2026 and 2034.
  • By segment, Corticosteroids emerged as the largest Treatment Type in terms of market size in 2025.
  • Corticosteroids is anticipated to remain the most attractive Treatment Type segment, recording the fastest growth during the forecast period.

Other Key Findings


  • In 2025, Australia represented 1.08% of the overall global Polymyositis Market size.
  • United States is projected to lead the global Polymyositis Market size by 2034.
  • Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2034.
  • Japan is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 49.22 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 13.79 Million
Market Size In 2034 USD 24.74 Million
Largest segment Corticosteroids
Units Revenue in USD Million
CAGR 6.66% (2026-2034)
Segmnetation Covered
Treatment Type
  1. Corticosteroids
  2. Immunosuppressants
  3. Biologics
  4. Others
Diagnosis Method
  1. Blood Tests
  2. Imaging Techniques
  3. Muscle Biopsy
  4. Electromyography
End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Research Institutes
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends